Skip to content
1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001321-0
2009-02-01
2025-12-10

Metrics

Loading full text...

Full text loading...

References

  1. Bassetti M., Repetto E., Righi E., Boni S., Diverio M., Molinari M. P., Mussap M., Artioli S., Ansaldi F. other authors 2008; Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections. J Antimicrob Chemother 61:417–420
    [Google Scholar]
  2. Catchpole C. R., Andrews J. M., Brenwald N., Wise R. 1997; A reassessment of the in-vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 39:255–260 [CrossRef]
    [Google Scholar]
  3. Gales A. C., Reis A. O., Jones R. N. 2001; Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39:183–190 [CrossRef]
    [Google Scholar]
  4. Girlich D., Naas T., Bellais S., Poirel L., Karim A., Nordmann P. 2000; Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei . Antimicrob Agents Chemother 44:1470–1478 [CrossRef]
    [Google Scholar]
  5. Janda J. M., Abbott S. L. 2006; The genus Hafnia : from soup to nuts. Clin Microbiol Rev 19:12–18 [CrossRef]
    [Google Scholar]
  6. Jones R. N., Anderegg T. R., Swenson J. M. the Quality Control Working Group 2005; Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods. J Clin Microbiol 43:925–927 [CrossRef]
    [Google Scholar]
  7. Kasiakou S. K., Michalopoulos A., Soteriades E. S., Samonis G., Sermaides G. J., Falagas M. E. 2005; Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 49:3136–3146 [CrossRef]
    [Google Scholar]
  8. Li J., Nation R. L., Milne R. W., Turnidge J. D., Coulthard K. 2005; Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 25:11–25 [CrossRef]
    [Google Scholar]
  9. Markou N., Apostolakos H., Koumoudiou C., Athanasiou M., Koutsoukou A., Alamanos I., Gregorakos L. 2003; Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 7:R78–R83 [CrossRef]
    [Google Scholar]
  10. Muyembe T., Vandepitte J., Desmyter J. 1973; Natural colistin resistance in Edwardsiella tarda . Antimicrob Agents Chemother 4:521–524 [CrossRef]
    [Google Scholar]
  11. NCCLS 2003 Performance Standards for Antimicrobial Disk Susceptibility Tests . Approved Standard M2-A8 Wayne, PA: National Committee for Clinical Laboratory Standards;
    [Google Scholar]
  12. Savini V., Catavitello C., Talia M., Di Berardino F., Manna A., Balbinot A., Febbo F., Carlino D., Fioritoni F. other authors 2008; Ulcer infection by ESBL-producing Proteus mirabilis : a case report. Int J Low Extrem Wounds 7:99–101 [CrossRef]
    [Google Scholar]
  13. Shimizu S., Iyobe S., Mitsuhashi S. 1977; Inducible high resistance to colistin in Proteus strains. Antimicrob Agents Chemother 12:1–3 [CrossRef]
    [Google Scholar]
  14. Tan T. Y., Ng S. Y. 2006; The in-vitro activity of colistin in gram-negative bacteria. Singapore Med J 47:621
    [Google Scholar]
  15. Thomson K. S., Sanders C. C., Washington J. A. II 1993; Ceftazidime resistance in Hafnia alvei . Antimicrob Agents Chemother 37:1375–1376 [CrossRef]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001321-0
Loading
/content/journal/jmm/10.1099/jmm.0.001321-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error